TNFRSF1A and pancreatic neoplasm: Blocking TWEAK in pancreatic cancer cell lines resulted in a 22–65% cell growth inhibition of these cells, highlighting the therapeutic potential of this specific TNFR ligand in pancreatic cancer [14].